Deoxyshikonin
Deoxyshikonin may be a new drug candidate for wound healing and treatment of lymphatic diseases. Deoxyshikonin enhances the ability of human dermal lymphatic microvascular endothelial cells (HMVEC-dLy) to undergo time-dependent in vitro cord formation. Deoxyshikonin and dodecyl gallate show significantly synergic antimicrobial activity with penicillin in vivo and in vitro, and can effectively reduce nasopharyngeal and lung colonization caused by different penicillin-resistant pneumococcal serotypes.
Product Specifications
CAS Number
43043-74-9
Product Name Alternative
Arnebin 7, Deoxyshikonin
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 33.33 mg/mL (122.40 mM)
Smiles
CC (=CCCC1=CC (=O) C2=C (C=CC (=C2C1=O) O) O) C
Molecular Formula
C16H16O4
Molecular Weight
272.3
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
1,4-Naphthalenedione, 5,8-dihydroxy-2- (4-methyl-3-pentenyl) -
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Human 14-3-3 tau/14-3-3 theta/YWHAQ Protein (GST Tag)
Isotype Control, Mouse IgG1 Kappa (IGG1/1331), CF660C Conjugate, 0.1 mg/mL
